158 related articles for article (PubMed ID: 19276397)
1. Neutropenic enterocolitis and docetaxel neoadjuvant chemotherapy.
Dumitra S; Sideris L; Leclerc Y; Leblanc G; Dubé P
Ann Oncol; 2009 Apr; 20(4):795-6. PubMed ID: 19276397
[No Abstract] [Full Text] [Related]
2. Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial.
Bono P; Kellokumpu-Lehtinen PL; Alanko T; Kokko R; Asola R; Turpeenniemi-Hujanen T; Jyrkkiö S; Kataja V; Leinonen M; Joensuu H
Ann Oncol; 2009 Mar; 20(3):595-6. PubMed ID: 19153112
[No Abstract] [Full Text] [Related]
3. [Poor outcome neutropenic enterocolitis after treatment with docetaxel in a breast cancer patient].
Cubo T; Padilla D; Villarejo P; López A; Delgado Y P Menéndez M
Rev Esp Enferm Dig; 2007 Aug; 99(8):480-2. PubMed ID: 18020871
[No Abstract] [Full Text] [Related]
4. [Taxanes in the adjuvant and neoadjuvant therapy of breast cancer].
Semiglazov VF; Semiglazov VV; Bozhok AA; Mel'nikova OA
Vopr Onkol; 2004; 50(2):243-9. PubMed ID: 15176231
[No Abstract] [Full Text] [Related]
5. [AIOM Conference 2004. Docetaxel: a recent conquest in the adjuvant therapy of breast cancer].
Adamo V
Tumori; 2004; 90(6):13-21. PubMed ID: 15762373
[No Abstract] [Full Text] [Related]
6. Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer.
Heys SD; Sarkar T; Hutcheon AW
Expert Opin Pharmacother; 2004 Oct; 5(10):2147-57. PubMed ID: 15461550
[TBL] [Abstract][Full Text] [Related]
7. Neutropenic enterocolitis associated with docetaxel therapy in a patient with breast cancer.
Rolston KV
Clin Adv Hematol Oncol; 2009 Aug; 7(8):527-8. PubMed ID: 19927979
[No Abstract] [Full Text] [Related]
8. Primary (neoadjuvant) chemotherapy with docetaxel in breast cancer.
Gradishar WJ
Clin Breast Cancer; 2001 Oct; 2 Suppl 1():S31-5. PubMed ID: 11970742
[TBL] [Abstract][Full Text] [Related]
9. Controversies in the adjuvant treatment of breast cancer: the role of taxanes.
Di Leo A; Ciarlo A; Panella M; Pozzessere D; Santini S; Vinci E; Biganzoli L
Ann Oncol; 2004; 15 Suppl 4():iv17-21. PubMed ID: 15477303
[No Abstract] [Full Text] [Related]
10. [Taxotere application in the management of breast cancer].
Bozhok AA; Semiglazov VF; Kletcel' AE; Arzumanov AS; Ivanova OA; Semiglazov VV
Vopr Onkol; 2005; 51(2):253-60. PubMed ID: 16223013
[No Abstract] [Full Text] [Related]
11. [Fatal neutropenic enterocolitis in a patient with castration-resistant prostate cancer treated with first-line chemotherapy].
Kongsted P; Sheikh K; Mouritsen LS; Lindberg H; Sengeløv L
Ugeskr Laeger; 2015 Jan; 177(2A):24-5. PubMed ID: 25612951
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of docetaxel for breast cancer.
Lwin Z; Leighl N
Expert Opin Pharmacother; 2009 Feb; 10(2):283-90. PubMed ID: 19236199
[TBL] [Abstract][Full Text] [Related]
13. [Taxanes as adjuvants in breast cancer. What repercussions will this have in clinical practice?].
Mosconi AM; Montedoro M
Suppl Tumori; 2004; 3(4):S18-20. PubMed ID: 15206203
[No Abstract] [Full Text] [Related]
14. Neutropenic enterocolitis affecting the transverse colon: an unusual complication of chemotherapy.
Ramsingh J; Bolln C; Hodnett R; Al-Ani A
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24792023
[TBL] [Abstract][Full Text] [Related]
15. Neutropenic enterocolitis in breast cancer patient after taxane-containing chemotherapy.
Oehadian A; Fadjari TH
Acta Med Indones; 2008 Jan; 40(1):29-33. PubMed ID: 18326897
[TBL] [Abstract][Full Text] [Related]
16. Taxanes: impact on breast cancer therapy.
Bachegowda LS; Makower DF; Sparano JA
Anticancer Drugs; 2014 May; 25(5):512-21. PubMed ID: 24552749
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
18. [Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer].
Bozhok AA; Semiglazov VF; Kletzel' AE; Arzumanov AS; Mel'nikova OA; Paltuev RM; Ivanova OA; Semiglazov VV
Vopr Onkol; 2006; 52(1):7-14. PubMed ID: 16715697
[No Abstract] [Full Text] [Related]
19. [Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer].
Fattoruso SI; Rossi S; Vici P; Di Filippo F; Botti C; Di Lauro L; Foggi P; Saracca E; Ferranti FR; Visca P; Lopez M
Clin Ter; 2008; 159(6):443-7. PubMed ID: 19169606
[TBL] [Abstract][Full Text] [Related]
20. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
Costa SD; von Minckwitz G; Raab G; Blohmer JU; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
